Clinical trial
Rituximab to Treat Stiff Person Syndrome
NCT00091897 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00091897 |
|---|---|
| Title | Rituximab to Treat Stiff Person Syndrome |
| Official title | Efficacy of Rituximab in Patients With Stiff Person Syndrome With Anti-GAD Antibodies: A Randomized Placebo-Controlled Trial |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stiff Person Syndrome |
| Intervention type | Drug |
| Interventions | Rituximab, rituximab or placebo |
| Enrollment | 24 |
| Start date | Sep 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | May 1, 2009 |
| First posted | Sep 20, 2004 |
| Last update posted | Aug 31, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: